|
Volumn 473, Issue 7347, 2011, Pages 253-254
|
Getting personal
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
CANCER CHEMOTHERAPY;
CLINICAL RESEARCH;
COST BENEFIT ANALYSIS;
ECONOMIC ASPECT;
EDITORIAL;
HEALTH CARE COST;
HEALTH CARE PLANNING;
HEALTH CARE SYSTEM;
HEALTH INSURANCE;
HEALTH SERVICE;
HUMAN;
MEDICAL EDUCATION;
MEDICAL RESEARCH;
MENTAL DISEASE;
PERSONALIZED MEDICINE;
PRIORITY JOURNAL;
SCIENTIST;
ANIMALS;
COST-BENEFIT ANALYSIS;
FRANCE;
HUMANS;
INDIVIDUALIZED MEDICINE;
INSURANCE, HEALTH;
MOLECULAR TARGETED THERAPY;
TRANSLATIONAL RESEARCH;
|
EID: 79956317678
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/473253b Document Type: Editorial |
Times cited : (11)
|
References (0)
|